These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8130129)
21. Modern approach to lymphoma diagnosis by fine-needle aspiration: restoring respect to a valuable procedure. Katz RL Cancer; 2005 Dec; 105(6):429-31. PubMed ID: 16222689 [No Abstract] [Full Text] [Related]
22. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions. Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579 [TBL] [Abstract][Full Text] [Related]
23. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231 [TBL] [Abstract][Full Text] [Related]
24. [Study of silver binding nucleolar organizer regions (AgNORs) in proliferative lesions of bronchi, colon and thyroid--semiautomatic computer image analysis]. Zaczek M Folia Med Cracov; 1996; 37(1-2):67-88. PubMed ID: 9312528 [TBL] [Abstract][Full Text] [Related]
25. [Significance of argyrophil staining for nucleolar organizer regions (AgNORs) to pathologic diagnosis of prostatic adenocarcinoma]. Cao X Zhonghua Wai Ke Za Zhi; 1996 Apr; 34(4):232-3. PubMed ID: 9387689 [TBL] [Abstract][Full Text] [Related]
26. Proliferative activities of epithelial and connective tissue cells in the rat periodontal regeneration using argyrophilic nucleolar organizer regions staining. Usuda J; Hashimoto S; Enokiya Y; Inoue T; Shimono M J Periodontal Res; 2004 Jun; 39(3):175-87. PubMed ID: 15102046 [TBL] [Abstract][Full Text] [Related]
27. Assessment of proliferative activity by AgNOR and PCNA in prostatic tissues of ram lambs implanted with zeranol. Gulbahar MY; Yuksel H; Guvenc T; Okut H Reprod Domest Anim; 2005 Oct; 40(5):468-74. PubMed ID: 16149954 [TBL] [Abstract][Full Text] [Related]
28. AgNORs and their relationship to cell size, histological grade, lymph node involvement, metastases, and survival pattern in carcinoma of the breast: a study from south India. Subramanian S; Shariff S; Andrade C J Surg Oncol; 1996 Jun; 62(2):139-43. PubMed ID: 8649041 [TBL] [Abstract][Full Text] [Related]
29. [Image analysis of AgNORs in esophageal balloon cytosmears]. Wang DY Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):30-3. PubMed ID: 8334937 [TBL] [Abstract][Full Text] [Related]
30. Cell adhesion molecule E-cadherin and cellular proliferation marker AgNOR in bladder lesions--usefulness and limitations. Menon MM; Simha M Indian J Cancer; 1998 Dec; 35(4):142-6. PubMed ID: 10388228 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of nucleolar organiser regions (AgNORs) in laryngeal cancer. Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szajowski K Acta Otorhinolaryngol Belg; 1998; 52(3):215-21. PubMed ID: 9810456 [TBL] [Abstract][Full Text] [Related]
32. [Significance of the AgNOR in tumor pathology]. Pich A; Margaria E; Chiusa L Pathologica; 2002 Feb; 94(1):2-9. PubMed ID: 11912874 [TBL] [Abstract][Full Text] [Related]
33. Use of the argyrophilic nucleolar region method for cytologic and histologic examination of the lymph nodes in dogs. Vajdovich P; Psáder R; Tóth ZA; Perge E Vet Pathol; 2004 Jul; 41(4):338-45. PubMed ID: 15232133 [TBL] [Abstract][Full Text] [Related]
34. [The observation of proliferative cell nuclear antigen and AgNORs in ocular adnexal lymphoid hyperplasia]. Wei R; Ye T; Cai J; Zhu H; Xi S Yan Ke Xue Bao; 1998 Jun; 14(2):66-8. PubMed ID: 12580033 [TBL] [Abstract][Full Text] [Related]
36. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270 [TBL] [Abstract][Full Text] [Related]
37. Critical analysis of the methods commonly employed in the assessment of cell proliferation: advantages of the NOR silver-staining technique in routine cyto-histopathology. Trerè D Anal Cell Pathol; 1993 Jul; 5(4):191-201. PubMed ID: 8363981 [TBL] [Abstract][Full Text] [Related]
38. AgNORs in duct epithelial lesions in chronic pancreatitis and in pancreas cancer cells. Cylwik B; Nowak HF; Puchalski Z; Zimnoch L; Dadan J Hepatogastroenterology; 1998; 45(22):1130-4. PubMed ID: 9756019 [TBL] [Abstract][Full Text] [Related]
39. Differential expression of the human MIXL1 gene product in non-Hodgkin and Hodgkin lymphomas. Drakos E; Rassidakis GZ; Leventaki V; Guo W; Medeiros LJ; Nagarajan L Hum Pathol; 2007 Mar; 38(3):500-7. PubMed ID: 17303500 [TBL] [Abstract][Full Text] [Related]
40. Re: quantitative evaluation of AgNORs in bone tumours. Arora B; Kumar S; Jindal K Pathology; 2004 Feb; 36(1):98. PubMed ID: 14757570 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]